HotMed.info

Gambro launches the next generation of high-flux dialyzers with Polyflux Revaclear and Polyflux Revaclear MAX

HotMed.info — Sat, 08 Nov 2008 08:42:30 +0000

Gambro launches the next generation of high-flux dialyzers with Polyflux Revaclear and Polyflux Revaclear MAX DENVER, Colo. — Gambro, a leader in advancing dialyzer technology for more than 40 years, announced today that it is introducing the latest innovation in dialyzer technology — Polyflux® Revaclear and Polyflux® Revaclear MAX. The Polyflux Revaclear dialyzers feature a proprietary [...]

Second Sight Completes U.S. Phase I Enrollment and Commences European Clinical Trial for the Argus II Retinal Implant

HotMed.info — Fri, 07 Nov 2008 09:43:35 +0000

Only long-term retinal prosthesis study underway worldwide offers hope for treating blindness Boston, MA, February 15, 2008 - Second Sight Medical Products Inc, a leading developer of retinal prostheses for treating blindness, announced today that it has completed enrollment of the first phase of a US FDA approved clinical study of the Argus™ II Retinal Prosthesis [...]

Permanent International Healthcare Marketplace And Education Center Set To Open In New York City In 2013

HotMed.info — Thu, 06 Nov 2008 12:39:38 +0000

NEW YORK, October 28, 2008 — The world’s first permanent international healthcare marketplace and education center will open in less than five years, the key players driving the project said today, as plans for the Midtown Manhattan tower have been finalized and marketing has begun. World Product Centre, as the project is known, has signed [...]

Philips introduces new, advanced light therapy device to offer quick relief from winter blues

HotMed.info — Thu, 06 Nov 2008 12:35:13 +0000

Murrysville, Pa., USA - Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the goLITE BLU, a natural, convenient way to offer quick relief from seasonal mood-related problems. With the end of Daylight Saving time many Americans are affected by the increased darkness and experience what is known as the winter blues. Symptoms of the [...]

Bakersfield’s stagnant pools boost West Nile

HotMed.info — Wed, 05 Nov 2008 10:28:30 +0000

One of the United States’ worst-hit cities for foreclosures in 2007 - Bakersfield - became an epicenter of West Nile virus that year largely due to mosquitoes breeding in abandoned swimming pools, UC Davis and Kern County scientists have reported. The Central Valley city had 140 diagnosed cases, up from 51 in 2006, or a [...]

Study: Folic acid, B vitamins offer no cancer protection

HotMed.info — Wed, 05 Nov 2008 10:19:33 +0000

Researchers have more disappointing news for people who hope to protect their health with vitamins. In the longest-running trial of its kind, doctors found that folic acid and other B vitamins didn’t prevent breast cancer or cancer in general, according to a seven-year study of 5,442 women in today’s Journal of the American Medical Association. Researchers randomly [...]

Docetaxel

HotMed.info — Thu, 25 Sep 2008 04:54:29 +0000

Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.[1][2] Docetaxel has an approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or [...]

Bevacizumab

HotMed.info — Thu, 25 Sep 2008 04:04:41 +0000

Bevacizumab (Avastin, Genentech/Roche) is a monoclonal antibody against vascular endothelial growth factor (VEGF). It is used in the treatment of cancer, where it inhibits tumor growth by blocking the formation of new blood vessels (angiogenesis). Bevacizumab was the first clinically available angiogenesis inhibitor in the United States. Bevacizumab has been approved by the U.S. Food and [...]

Irbesartan

HotMed.info — Thu, 25 Sep 2008 03:56:40 +0000

Irbesartan (INN) (pronounced /ɜrbəˈsɑrtən/) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro. Indications As with all angiotensin II receptor antagonists, irbesartan is indicated for the [...]

Cetirizine

HotMed.info — Thu, 25 Sep 2008 03:41:06 +0000

Cetirizine hydrochloride, an antihistamine, (pronounced /sɛˈtɪrɨziːn/) is a major metabolite of hydroxyzine, and a racemic selective H1 receptor inverse agonist used in the treatment of allergies, hay fever, angioedema, and urticaria. The structural similarity of cetirizine to hydroxyzine, and its derivation from piperazine, attribute similar adverse reactions and properties to other piperazine derivatives. Formerly prescription-only in [...]